The notable peptide vaccines that have undergone phase I/II/III clinical trials include HER-2/neu immunodominant peptide (lung, breast, or ovarian cancer) [6971], Mucin-1 (MUC-1, Stimuvax), peptide (breast or colon cancer) [72, 73], Carcinoembryonic antigen (colorectal, gastric, breast, pancreatic and non-small-cell lung cancers) [74, 75], Prostate-specific membrane antigen (prostate cancer) [7678], HPV-16 E7 peptide (cervical cancer) [79], Ras oncoprotein peptide (colorectal and pancreatic carcinomas) [8082], and Melanoma antigens (Melanoma) [62, 68, 8385]
10.1074/jbc.M301362200 J
Meeting the recommended daily intake of 2.4 mcg becomes easy with modest animal product consumption
This kind of simulation can give us views of how atoms and biomolecules interact with each other, and which parts are essential for this interaction, Zhang says
122 MiyazawaT.MatsumotoK.OhmichiH.KatohH.YamashimaT.NakamuraT
This process ensures that every Cenexa peptide pill delivers true molecular integrity and repeatable, measurable outcomes for serious researchers